DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Fundamental Analysis & Valuation

FRA:DBAN • DE000A1TNUT7

Current stock price

24.6 EUR
-0.15 (-0.61%)
Last:

This DBAN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DBAN.DE Profitability Analysis

1.1 Basic Checks

  • DBAN had positive earnings in the past year.
  • In the past year DBAN had a positive cash flow from operations.
  • In multiple years DBAN reported negative net income over the last 5 years.
  • In multiple years DBAN reported negative operating cash flow during the last 5 years.
DBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFDBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of DBAN (3.38%) is better than 67.50% of its industry peers.
  • DBAN's Return On Equity of 4.81% is in line compared to the rest of the industry. DBAN outperforms 47.50% of its industry peers.
  • DBAN has a Return On Invested Capital (2.53%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROIC 2.53%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
DBAN.DE Yearly ROA, ROE, ROICDBAN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • The Profit Margin of DBAN (31.10%) is better than 79.17% of its industry peers.
  • In the last couple of years the Profit Margin of DBAN has declined.
  • Looking at the Operating Margin, with a value of 32.22%, DBAN is in the better half of the industry, outperforming 71.67% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DBAN has declined.
  • DBAN has a better Gross Margin (89.98%) than 90.83% of its industry peers.
  • DBAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
DBAN.DE Yearly Profit, Operating, Gross MarginsDBAN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DBAN.DE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for DBAN has been reduced compared to 1 year ago.
  • The number of shares outstanding for DBAN has been increased compared to 5 years ago.
  • DBAN has a worse debt/assets ratio than last year.
DBAN.DE Yearly Shares OutstandingDBAN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DBAN.DE Yearly Total Debt VS Total AssetsDBAN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • DBAN has an Altman-Z score of 1.78. This is a bad value and indicates that DBAN is not financially healthy and even has some risk of bankruptcy.
  • DBAN has a better Altman-Z score (1.78) than 67.50% of its industry peers.
  • DBAN has a debt to FCF ratio of 93.97. This is a negative value and a sign of low solvency as DBAN would need 93.97 years to pay back of all of its debts.
  • DBAN's Debt to FCF ratio of 93.97 is fine compared to the rest of the industry. DBAN outperforms 60.83% of its industry peers.
  • DBAN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.31, DBAN is in the better half of the industry, outperforming 68.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Altman-Z 1.78
ROIC/WACCN/A
WACCN/A
DBAN.DE Yearly LT Debt VS Equity VS FCFDBAN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • DBAN has a Current Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of DBAN (0.84) is comparable to the rest of the industry.
  • A Quick Ratio of 0.84 indicates that DBAN may have some problems paying its short term obligations.
  • DBAN has a Quick ratio of 0.84. This is comparable to the rest of the industry: DBAN outperforms 56.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
DBAN.DE Yearly Current Assets VS Current LiabilitesDBAN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DBAN.DE Growth Analysis

3.1 Past

  • The earnings per share for DBAN have decreased strongly by -39.70% in the last year.
  • DBAN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.13% yearly.
  • The Revenue for DBAN has decreased by -10.87% in the past year. This is quite bad
  • DBAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%

3.2 Future

  • Based on estimates for the next years, DBAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.41% on average per year.
  • The Revenue is expected to decrease by -6.93% on average over the next years.
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.41%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DBAN.DE Yearly Revenue VS EstimatesDBAN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 50M -50M 100M 150M 200M
DBAN.DE Yearly EPS VS EstimatesDBAN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. DBAN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.85 indicates a correct valuation of DBAN.
  • 65.83% of the companies in the same industry are more expensive than DBAN, based on the Price/Earnings ratio.
  • DBAN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.73.
  • The Price/Forward Earnings ratio is 12.22, which indicates a correct valuation of DBAN.
  • Based on the Price/Forward Earnings ratio, DBAN is valued cheaper than 80.83% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DBAN to the average of the S&P500 Index (23.72), we can say DBAN is valued slightly cheaper.
Industry RankSector Rank
PE 16.85
Fwd PE 12.22
DBAN.DE Price Earnings VS Forward Price EarningsDBAN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • DBAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 224.94
EV/EBITDA N/A
DBAN.DE Per share dataDBAN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • DBAN's earnings are expected to decrease with -15.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DBAN.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.04%, DBAN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 3.27, DBAN pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, DBAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.04%

5.2 History

  • The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
DBAN.DE Yearly Dividends per shareDBAN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 73.85% of the earnings are spent on dividend by DBAN. This is not a sustainable payout ratio.
  • The Dividend Rate of DBAN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP73.85%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
DBAN.DE Yearly Income VS Free CF VS DividendDBAN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
DBAN.DE Dividend Payout.DBAN.DE Dividend Payout, showing the Payout Ratio.DBAN.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DBAN.DE Fundamentals: All Metrics, Ratios and Statistics

DEUTSCHE BETEILIGUNGS AG

FRA:DBAN (3/20/2026, 12:09:05 PM)

24.6

-0.15 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners11.47%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap462.48M
Revenue(TTM)96.86M
Net Income(TTM)30.13M
Analysts86.15
Price Target36.81 (49.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.04%
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP73.85%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.85
Fwd PE 12.22
P/S 4.77
P/FCF 224.94
P/OCF 174.85
P/B 0.74
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)1.46
EY5.93%
EPS(NY)2.01
Fwd EY8.18%
FCF(TTM)0.11
FCFY0.44%
OCF(TTM)0.14
OCFY0.57%
SpS5.15
BVpS33.3
TBVpS30.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.08
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROCE 3.86%
ROIC 2.53%
ROICexc 2.68%
ROICexgc 2.85%
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
FCFM 2.12%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-35.11%
ROICexgc growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 6.82%
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 1.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.41%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%
EBIT growth 1Y-37.36%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-64.73%
EBIT Next 3Y-9.54%
EBIT Next 5Y-15.44%
FCF growth 1Y109.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.05%
OCF growth 3YN/A
OCF growth 5YN/A

DEUTSCHE BETEILIGUNGS AG / DBAN.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBAN.DE.


What is the valuation status of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Fairly Valued.


What is the profitability of DBAN stock?

DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 4 / 10.


What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.


What is the earnings growth outlook for DEUTSCHE BETEILIGUNGS AG?

The Earnings per Share (EPS) of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is expected to decline by -71.64% in the next year.